Literature DB >> 27867328

Association Between Erectile Function and Biomarkers of Subclinical Atherosclerosis: A Study Based on Middle-Aged Healthy Men from the General Population.

Saad Elzanaty1, Babak Rezanezhad2, Ronnie Willenheimer3, Rasmus Borgquist4.   

Abstract

INTRODUCTION: Epidemiological studies suggest atherosclerosis as a common risk factor between cardiovascular diseases and erectile dysfunction (ED). We aimed to determine the association between erectile function and the biomarkers of subclinical atherosclerosis in 119 middle-aged healthy men from the general population.
METHODS: Erectile function was assessed using the International Index of Erectile Function-5 (IIEF-5). Serum levels of biomarkers of atherosclerosis: Apolipoprotein A, Apolipoprotein B, fibrinogen, and C-reactive protein (CRP) were measured. In addition, demographic data was collected.
RESULTS: The mean (SD) of age was 55 years (± 4.0). The prevalence of ED was 50%. There was a negative significant correlation between IIEF-5 and CRP levels (r = -0.20, p = 0.02), and BMI (r = -0.20, p = 0.03), respectively. No significant correlations between IIEF-5 and serum levels of Apolipoprotein A, Apolipoprotein B, and fibrinogen were found (p > 0.05). A positive significant correlation was found between BMI and fibrinogen (r = 0.20, p = 0.01), CRP (r = 0.30, p = 0.001). In a multivariate logistic regression model with IIEF-5 as the dependent variable, CRP was the only biomarker that predicted ED (odds ratio = 1.350; 95 % CI: 1.044-1.754).
CONCLUSIONS: These results indicate that CRP is a biomarker of subclinical atherosclerosis associated with ED. This association seems to be linked to greater BMI among such men.

Entities:  

Keywords:  Atherosclerosis; CRP; Erectile dysfunction; Obesity

Year:  2016        PMID: 27867328      PMCID: PMC5109965          DOI: 10.1159/000442865

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  21 in total

1.  Erectile dysfunction: is there silent obstructive coronary artery disease?

Authors:  P D O'Kane; G Jackson
Journal:  Int J Clin Pract       Date:  2001-04       Impact factor: 2.503

Review 2.  Role of oxidative modifications in atherosclerosis.

Authors:  Roland Stocker; John F Keaney
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

3.  Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction. A preliminary study.

Authors:  M E Sullivan; M A Miller; C R Bell; I A Jagroop; C S Thompson; M A Khan; R J Morgan; D P Mikhailidis
Journal:  Int Angiol       Date:  2001-09       Impact factor: 2.789

4.  C-reactive protein makes human endothelium stiff and tight.

Authors:  Kristina Kusche-Vihrog; Katarina Urbanova; Anja Blanqué; Marianne Wilhelmi; Hermann Schillers; Katrin Kliche; Hermann Pavenstädt; Eva Brand; Hans Oberleithner
Journal:  Hypertension       Date:  2010-12-13       Impact factor: 10.190

5.  Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial.

Authors:  Rena R Wing; Raymond C Rosen; Joseph L Fava; Judy Bahnson; Frederick Brancati; Isaias Noel C Gendrano Iii; Abbas Kitabchi; Stephen H Schneider; Thomas A Wadden
Journal:  J Sex Med       Date:  2009-08-17       Impact factor: 3.802

Review 6.  Epidemic inflammation: pondering obesity.

Authors:  Carl Nathan
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 7.  Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links.

Authors:  Charalambos Vlachopoulos; Konstantinos Rokkas; Nikolaos Ioakeimidis; Christodoulos Stefanadis
Journal:  Eur Urol       Date:  2007-08-13       Impact factor: 20.096

8.  Factors associated with sex hormones and erectile dysfunction in male Taiwanese participants with obesity.

Authors:  Ming-Der Shi; Jian-Kang Chao; Mi-Chia Ma; Lyh-Jyh Hao; I-Chen Chao
Journal:  J Sex Med       Date:  2013-10-31       Impact factor: 3.802

9.  Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.

Authors:  Katherine Esposito; Francesco Giugliano; Carmen Di Palo; Giovanni Giugliano; Raffaele Marfella; Francesco D'Andrea; Massimo D'Armiento; Dario Giugliano
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

Review 10.  ED2: erectile dysfunction = endothelial dysfunction.

Authors:  André T Guay
Journal:  Endocrinol Metab Clin North Am       Date:  2007-06       Impact factor: 4.741

View more
  3 in total

1.  Is the plasma endocan level a reliable predictor for the severity of erectile dysfunction?

Authors:  Özkan Onuk; Burak Arslan; Tugrul Cem Gezmis; Bugra Çetin; Taha Göv; Gökhan Yazıcı; Okan Gürkan; Enver Ozdemir
Journal:  Int Urol Nephrol       Date:  2018-07-27       Impact factor: 2.370

2.  Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes.

Authors:  Haifa Maalmi; Christian Herder; Gidon J Bönhof; Klaus Strassburger; Oana-Patricia Zaharia; Wolfgang Rathmann; Volker Burkart; Julia Szendroedi; Michael Roden; Dan Ziegler
Journal:  Diabetologia       Date:  2021-11-20       Impact factor: 10.460

3.  Endocan and Erectile Dysfunction.

Authors:  Sevket Balta; Dimitri P Mikhailidis
Journal:  Am J Mens Health       Date:  2019 Nov-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.